| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00014 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -9.7e-05 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 1.5e-05 | 1 |